RNS Number : 5831W
Burberry Group PLC
16 July 2024
 

Burberry Group plc (the "Company") - Director/PDMR Shareholding

 

The Company announces that it has today received notification that Dr Gerry Murphy, Chair and a Non-Executive Director of the Company, purchased 20,000 Ordinary Shares of 0.05 pence each in the Company ("Shares") on Tuesday, 16 July 2024 at an aggregate price of 725.0635 pence per Share.

 

16 July 2024

 

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 as it forms part of UK law.

Notification of dealing form

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Gerard Martin Murphy

2

Reason for the notification

a)

Position/status

Chair and Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Burberry Group plc

b)

LEI

213800PE1KEFCNFR1R50

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05 pence each

 

 

GB0031743007

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£7.250635

 

20,000

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate

Total

 £7.250635

20,000

£145,012.70

e)

Date of the transaction

2024-07-16

 

f)

Place of the transaction

XLON





 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLTDRIRLIS